» Articles » PMID: 29728768

Therapeutic Decisions in ALS Patients: Cross-cultural Differences and Clinical Implications

Abstract

Objective: Quantitative analysis of decision-making on therapeutic options in different sociocultural context in amyotrophic lateral sclerosis (ALS).

Methods: ALS patients (n = 244) were consecutively recruited in Germany (n = 83), Poland (n = 83), and Sweden (n = 78) in a prospective cross-cultural study ( www.NEEDSinALS.com ). They were interviewed on preferences for therapeutic techniques including invasive (IV) and non-invasive ventilation (NIV), as well as percutaneous endoscopic gastrostomy (PEG) and on hypothetical termination of these using quantitative questions. Using standardized questionnaires, religiousness, personal values, quality of life, and depressiveness were assessed.

Results: NIV was most frequently used in Germany and PEG in Sweden. Swedish patients were most liberal on initiation and termination of PEG, NIV and IV. Polish patients were mostly undecided and were least likely to consider discontinuing supportive management. Current use was partly associated with age, gender and state of physical function; also, financial support explained some variance. Future preferences on therapeutic options from the patient's perspective were also closely associated with cultural factors. The more oriented towards traditional and conservative values, the less likely patients were to decide for invasive therapeutic devices (IV, PEG), the least likely to have ideations to discontinue any device and the more likely to have an undecided attitude.

Conclusions: Current use of therapeutic options is determined by medical condition in analogy to clinical guidelines. For future considerations, other factors such as cultural background are crucial, yielding hurdles to be regarded in the implementation of advanced directives in a multicultural environment.

Citing Articles

Brain Function, Learning, and Role of Feedback in Complete Paralysis.

Silvoni S, Occhigrossi C, Di Giorgi M, Lule D, Birbaumer N Sensors (Basel). 2024; 24(19).

PMID: 39409405 PMC: 11478792. DOI: 10.3390/s24196366.


The Role of Ferroptosis in Amyotrophic Lateral Sclerosis Treatment.

Wang L, Zhang L, Bai X, Qiang R, Zhang N, Hu Q Neurochem Res. 2024; 49(10):2653-2667.

PMID: 38864944 DOI: 10.1007/s11064-024-04194-w.


Enteral tube feeding for amyotrophic lateral sclerosis/motor neuron disease.

Sulistyo A, Abrahao A, Freitas M, Ritsma B, Zinman L Cochrane Database Syst Rev. 2023; 8:CD004030.

PMID: 37579081 PMC: 10413437. DOI: 10.1002/14651858.CD004030.pub4.


Quality of life and depression in patients with amyotrophic lateral sclerosis - does the country of origin matter?.

Ciecwierska K, Lule D, Bielecki M, Helczyk O, Maksymowicz-Sliwinska A, Finsel J BMC Palliat Care. 2023; 22(1):72.

PMID: 37312136 PMC: 10262126. DOI: 10.1186/s12904-023-01189-2.


The experiences of patients with amyotrophic lateral sclerosis of their decision-making processes to invasive home mechanical ventilation-A qualitative study.

Thorborg T, Finderup J, Winther D, Lorenzen C, Dreyer P Nurs Open. 2023; 10(8):5139-5148.

PMID: 37071691 PMC: 10333840. DOI: 10.1002/nop2.1749.


References
1.
Hogden A, Foley G, Henderson R, James N, Aoun S . Amyotrophic lateral sclerosis: improving care with a multidisciplinary approach. J Multidiscip Healthc. 2017; 10:205-215. PMC: 5446964. DOI: 10.2147/JMDH.S134992. View

2.
Connolly S, Galvin M, Hardiman O . End-of-life management in patients with amyotrophic lateral sclerosis. Lancet Neurol. 2015; 14(4):435-42. DOI: 10.1016/S1474-4422(14)70221-2. View

3.
Andersen P, Abrahams S, Borasio G, de Carvalho M, Chio A, Van Damme P . EFNS guidelines on the clinical management of amyotrophic lateral sclerosis (MALS)--revised report of an EFNS task force. Eur J Neurol. 2011; 19(3):360-75. DOI: 10.1111/j.1468-1331.2011.03501.x. View

4.
Leigh P, Abrahams S, Al-Chalabi A, Ampong M, Goldstein L, Johnson J . The management of motor neurone disease. J Neurol Neurosurg Psychiatry. 2003; 74 Suppl 4:iv32-iv47. PMC: 1765641. DOI: 10.1136/jnnp.74.suppl_4.iv32. View

5.
Desport J, Preux P, Truong T, Vallat J, Sautereau D, Couratier P . Nutritional status is a prognostic factor for survival in ALS patients. Neurology. 1999; 53(5):1059-63. DOI: 10.1212/wnl.53.5.1059. View